Everest Medicines announced on Dec. 11, 2025 that its wholly-owned subsidiary, Everest Medicines (China) Co., Ltd (Everest Medicines China), has…
Browsing: Pharma
Since 2025, driven by both policy tailwinds and fundamental strengths, the innovative drug sector in the Hong Kong stock market…
Partnership drives clinical research, hands-on student training, and access to cutting-edge medical technologies AdipoLABs Co., Ltd. and Red & Blue…
Strategic Partnership to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad’s Genome Valley, Enhancing Global Production and Supply of Isotopically…
With ISOAPI-D, CIL offers pharmaceutical partners a secure, global supply of deuterated reagents – manufactured to the highest quality standards…
Enterprise platform, queried through natural language, to help pharma, biotech, and investors make better decisions. High-quality biological patient data, enriched…
TruMerit, a leader in global healthcare workforce development, is partnering with EnGen, a workforce-aligned English language learning solution, to support…
TruMerit, a global leader in healthcare workforce development, today launched two new global credentials for healthcare workers specializing in rehabilitation,…
In a new survey, foreign-educated nurses and other healthcare professionals who migrate to work in the United States continue to…
AGFA HealthCare has been recognized by KLAS Research for significant satisfaction gains. Customer satisfaction with AGFA’s Enterprise Imaging VNA and…
iRad Hospital, the pioneering resort medical facility located at Studio City, today announced the signing of a cooperation agreement with Hong…
Kangji Medical Holdings Limited (Kangji Medical or the Company, HKG: 9997) and Knight Bidco Limited (the Offeror) today announced that…
Everest Medicines (HKG:1952) today announced that it has acquired an exclusive license with Visara, Inc. (Visara), a subsidiary of NovaBridge…
Hong Kong Department of Health accepts NDA for dorzagliatin, the world’s first approved glucokinase activator (GKA). Builds on China approval…
Nadzim Johan, Chief Activist of Muslim Consumers Association of Malaysia (Persatuan Pengguna Islam Malaysia or PPIM) (L) and Rajen Manickar,…
Company leverages dual-market strategy and technology-driven standardization to strengthen its leadership in China’s TCM sector and enter international markets. Sichuan…
On August 29, Everest Medicines (HKG: 1952) announced its interim results for the six months ended June 30, 2025. The…
ADC pipeline with multiple products entering key clinical stages Revenue increased by 350% year-on-year Focusing on the field of tumor…
In the first half of 2025, the structural transformation of the pharmaceutical industry continued to deepen. Driven by favorable policies,…
Australian Company Announces Landmark Paper Showing Cyclodextrin Therapy Reverses Heart Disease, Hailed as ‘Greatest Development Since Statins’ Cholrem Pty Ltd,…